Review and critique of opioid rotation practices and associated risks of toxicity
- PMID: 22458884
- DOI: 10.1111/j.1526-4637.2012.01357.x
Review and critique of opioid rotation practices and associated risks of toxicity
Erratum in
- Pain Med. 2012 Dec;13(12):1667
Abstract
Objectives: A dramatic increase in unintentional deaths from opioids has occurred over the past decade with strong inference that many of these deaths may be resulting from prescriber's error. Recent evidence suggests that the use of dose conversion ratios published in equianalgesic tables may lead to fatal or near-fatal opioid overdoses. The objective of this review was to determine whether the current practice of opioid rotation may be contributing to high rate of unintentional deaths.
Methods: We performed a focused literature review to identify reports of fatal or near-fatal outcomes that have occurred in conjunction with opioid rotation, to evaluate clinician competence in opioid rotation, and to identify inconsistencies in published protocols for opioid rotation. Further information was obtained by reviewing dosing instructions contained in product labels for extended-release formulations of several opioids.
Results: An increasing body of literature suggests that widely used opioid rotation practices, including the use of dose conversion ratios found in equianalgesic tables, may be an important contributor to the increasing incidence of opioid-related fatalities. These errors may be due, in part, not only to inadequate prescriber's competence but also to proliferation of inconsistent guidelines for opioid rotation, conflation of equianalgesic tables as conversion tables, and limitations inherent in the equianalgesic dose tables.
Conclusions: Most of the fatal outcomes occurring during opioid rotation are preventable. The current process being used for opioid rotation has important flaws that must be corrected.
Wiley Periodicals, Inc.
Similar articles
-
Overdose deaths demand a new paradigm for opioid rotation.Pain Med. 2012 Apr;13(4):571-4. doi: 10.1111/j.1526-4637.2012.01356.x. Epub 2012 Mar 28. Pain Med. 2012. PMID: 22458858
-
Opioid equianalgesic tables: are they all equally dangerous?J Pain Symptom Manage. 2009 Sep;38(3):409-17. doi: 10.1016/j.jpainsymman.2009.06.004. J Pain Symptom Manage. 2009. PMID: 19735901
-
Opioid rotation in clinical practice.Adv Ther. 2012 Oct;29(10):849-63. doi: 10.1007/s12325-012-0051-7. Epub 2012 Sep 25. Adv Ther. 2012. PMID: 23054690 Review.
-
Opioid conversions in acute care.Ann Pharmacother. 2007 Feb;41(2):255-66. doi: 10.1345/aph.1H421. Epub 2007 Feb 13. Ann Pharmacother. 2007. PMID: 17299011 Review.
-
Why equianalgesic tables are only part of the answer to equianalgesia.Ann Palliat Med. 2020 Mar;9(2):537-541. doi: 10.21037/apm.2020.03.05. Epub 2020 Mar 17. Ann Palliat Med. 2020. PMID: 32233628 Review.
Cited by
-
Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS).RMD Open. 2024 Aug 7;10(3):e004631. doi: 10.1136/rmdopen-2024-004631. RMD Open. 2024. PMID: 39117446 Free PMC article.
-
Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline.Support Care Cancer. 2024 Jul 24;32(8):542. doi: 10.1007/s00520-024-08710-0. Support Care Cancer. 2024. PMID: 39046534 Review.
-
Peri-OPerative Pain Management, Education & De-escalation (POPPMED), a novel anaesthesiologist-led program, significantly reduces acute and long-term postoperative opioid requirements: a retrospective cohort study.Pain Rep. 2022 Aug 23;7(5):e1028. doi: 10.1097/PR9.0000000000001028. eCollection 2022 Sep-Oct. Pain Rep. 2022. PMID: 36034601 Free PMC article.
-
Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey.J Palliat Med. 2022 Oct;25(10):1557-1562. doi: 10.1089/jpm.2022.0266. Epub 2022 Aug 5. J Palliat Med. 2022. PMID: 35930252 Free PMC article.
-
Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone.Drug Alcohol Depend. 2021 Sep 1;226:108869. doi: 10.1016/j.drugalcdep.2021.108869. Epub 2021 Jun 25. Drug Alcohol Depend. 2021. PMID: 34216862 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
